Skip to main content
Premium Trial:

Request an Annual Quote

Doug Fisher, Arnold Oronsky

Doug Fisher has joined Sera Prognostics as chief business officer. The company also has appointed Arnold Oronsky to its board. Fisher has been a partner at venture capital firm InterWest Partners and served on Sera's board starting in late 2011. Sera said that he has resigned as a director in connection to his joining the company's management team. 

Oronsky is a general partner at InterWest and has investment experience in diagnostics and pharmaceutical companies, Sera said. Before joining InterWest, he was vice president of discovery research at Lederle Laboratories, a division of American Cyanamid.

The Scan

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.